CNC vs EOLS · P/E 8.4, rev $163.07B vs rev $266.3M
Centene Corp (CNC) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the CNC and EOLS stock pages for the full models.
Not investment advice.